文献

J-GLOBAL ID：201602287553129216   整理番号：16A1100515

進行した肺腺がんにおいてERK1/2のリン酸化の上昇は化学治療の転帰の悪化と予後不良に関連する

Increased phosphorylation of ERK1/2 is associated with worse chemotherapeutic outcome and a poor prognosis in advanced lung adenocarcinoma

著者 (10件)： Tsujino Ichiro (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Nakanishi Yoko (Division of Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan) ,  Hiranuma Hisato (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Shimizu Tetsuo (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Hirotani Yukari (Division of Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan) ,  Ohni Sumie (Division of Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan) ,  Ouchi Yasushi (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Takahashi Noriaki (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Nemoto Norimichi (Division of Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan) ,  Hashimoto Shu (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan)
資料名： Medical Molecular Morphology  (Medical Molecular Morphology)
巻： 49  号： 2  ページ： 98-109  発行年： 2016年06月 
JST資料番号： L1883A  ISSN： 1860-1480  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 細胞外シグナル調節キナーゼ(ERK)1/2経路は増殖因子や腫...

シソーラス用語： *腺癌 ,...
準シソーラス用語： Erk1/2 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1100515&from=J-GLOBAL&jstjournalNo=L1883A") }}

著者キーワード (6件)： Lung adenocarcinoma ,  EGFR ,  KRAS ,  pERK1/2 ,  Chemotherapy ,  Prognosis

分類 (2件)： 呼吸器の腫よう  (GI04000G) ,  臨床腫よう学一般  (GE03010Y)

引用文献 (49件)：

• American Cancer Society: Cancer Facts and Figures 2007 (2007) American Cancer Society, Atlanta
• Hirsch FR, Corrin B, Colby TV (2004) World Health Organization classification of tumours. In: Travis WB, Brambilla A, Muller-Hermelinck HK, Harris CC (eds) Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press Lyon, France, p 10
• Sato M, Shames DS, Gazdar AF, Minna JD (2007) A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2:327-343
• Pao W, Girard N (2011) New driver mutations in non-small-cell lung cancer. Lancet Oncol 12:175-180
• Chappell WH, Steelman LS, Long JM, Kempf RC, Abrams SL, Franklin RA, Bäsecke J, Stivala F, Donia M, Fagone P, Malaponte G, Mazzarino MC, Nicoletti F, Libra M, Maksimovic-Ivanic D, Mijatovic S, Montalto G, Cervello M, Laidler P, Milella M, Tafuri A, Bonati A, Evangelisti C, Cocco L, Martelli AM, McCubrey JA (2011) Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget 2:135-164

タイトルに関連する用語 (7件)： 肺腺がん ,  ERK1 ,  リン酸化 ,  化学治療 ,  転帰 ,  悪化 ,  予後不良